Results 91 to 100 of about 5,373,856 (290)

Vascular Disease, Non‐Steroidal Anti‐Inflammatory Drugs and Risk of Parkinson's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives A history of vascular disease has been shown to be associated with an increased risk of Parkinson's disease, but this may be due to reverse causation. In addition, non‐steroidal anti‐inflammatory drugs are thought to reduce Parkinson's disease risk, but evidence is inconsistent and confounding by prior vascular disease is possible ...
Clare Wotton   +4 more
wiley   +1 more source

Long duration exercise program in individuals with parkinson´s disease: effects on functional capacity

open access: yes, 2014
The aim of this study was to investigate the effects of long duration exercise program on physical fitness components of functional capacity in individuals with Parkinson disease (PD) and to evaluate ongoing effects of exercise after 8 to 10-week follow ...
Stella, Florindo   +6 more
core   +2 more sources

Parkinson′s disease

open access: yesAnnals of Indian Academy of Neurology, 2011
Behari, Madhuri   +11 more
  +8 more sources

Stage‐Dependent β‐Synuclein Links MRI and Cognitive Decline in Alzheimer's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Synaptic degeneration drives cognitive decline in Alzheimer's disease (AD), but synaptic biomarkers are scarce. Brain‐enriched β‐synuclein emerged as a synaptic damage marker. We investigated its diagnostic, prognostic, and structural correlates across the AD continuum.
Ulaş Ay   +15 more
wiley   +1 more source

Data‐Driven SuStaIn Model of Disability Progression in Amyotrophic Lateral Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To determine whether ordinal Subtype and Stage Inference (SuStaIn) applied to routine ALSFRS‐R item scores can identify reproducible disability progression patterns in amyotrophic lateral sclerosis (ALS) and provide clinically meaningful staging.
Giammarco Milella   +5 more
wiley   +1 more source

Parkinson Disease

open access: yesContinuum
Parkinson disease (PD) is a neurodegenerative movement disorder that is increasing in prevalence especially as the population continues to age. This article provides an overview of the clinical presentation and evaluation for PD, genetic and environmental risk factors, and current treatments.New treatments for motor symptoms of PD (eg, motor ...
Zafar S, Lui F, Yaddanapudi SS.
europepmc   +5 more sources

Metabolic Parkinson’s disease

open access: yesFrontiers in Aging Neuroscience
Parkinson’s disease (PD) is a neurodegenerative disorder primarily characterized by the loss of dopaminergic neurons in the substantia nigra. While most cases are sporadic, there is growing evidence of a link between PD and metabolic dysfunctions such as
Federica Invernizzi   +13 more
doaj   +1 more source

Clinical characteristics of Parkinson disease cohort.

open access: yes, 2018
Clinical characteristics of Parkinson disease cohort.
Oluwadamilola O. Ojo (6038012)   +6 more
core   +1 more source

Alzheimer's Disease Biomarkers Measured by Capillary Blood Collection Versus Venous Plasma and Cerebrospinal Fluid

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Blood biomarkers are increasingly critical for non‐invasive Alzheimer's Disease (AD) diagnostics and research but typically require on‐site processing. Remote point‐of‐care collection methods could enhance biomarker testing in clinical and research settings.
Sara Ho   +9 more
wiley   +1 more source

Other title: Mark Parkinson Becomes Kansas' Forty Fifth Governor Other title: [Inaugural Speeches of Governor Mark Parkinson] Other title: [Inaugural Speeches]

open access: yes, 2009
application/pdf; "April 28, 2009.; "Remarks as prepared for delivery by Governor Mark Parkinson.; Some alternate titles supplied by ...
Kansas. Governor (2009-2011 : Parkinson)
core   +1 more source

Home - About - Disclaimer - Privacy